The Toronto Star reports on the Vioxx class action lawsuit and Pharmaceutical giant Merck has agreed to pay between $21.8 and $36.8 million to settle the case.For full story, please click here.
News & Views
The more you understand, the easier it is to manage well.View Blog
16 Sep 2021
Securities misrepresentation class action gone wrong – Superior Court denies leave under section 138.3 of the Ontario Securities Act and refuses certification of remaining claims
In Badesha v Cronos Group, Justice Morgan denied the plaintiff’s motions for leave to procee…